AspiAir GmbH
Gemünden (Wohra), DE · 1 known investors
AspiAir is a clinical-stage biotech company developing LASAG Inhale, an inhaled non-opioid treatment for pain and migraine attacks using acetylsalicylic acid. The company serves patients in the EU who lack access to adequate migraine medications and aims to provide a safe, mobile alternative to current therapies.
Founders & leadership
DS
Dr. Stefan DegenhardtManaging Director & CFO
DS
Dr. Sebastian CanisiusChief Medical Officer
DK
Dr. Karlheinz NockerProject Manager
Investors · 1
Frequently asked questions
- What does AspiAir GmbH do?
- AspiAir is a clinical-stage biotech company developing LASAG Inhale, an inhaled non-opioid treatment for pain and migraine attacks using acetylsalicylic acid. The company serves patients in the EU who lack access to adequate migraine medications and aims to provide a safe, mobile alternative to current therapies.
- Who are AspiAir GmbH's investors?
- AspiAir GmbH's investors include ATON GmbH.
- Where is AspiAir GmbH headquartered?
- AspiAir GmbH is headquartered in Gemünden (Wohra), DE.